Abstract:Background & aims: We aim to describe the liver immune microenvironment by analyzing liver biopsies from patients with chronic HBV infection (CHB). Host immune cell signatures and their corresponding localization were characterized by analyzing the intrahepatic transcriptome in combination with a custom multiplex immunofluorescence panel. Method: Matching FFPE and fresh frozen liver biopsies were collected from immune active patients within the open-label phase IV study GS-US-174-0149. RNA-Seq was conducted on 53 CHB liver biopsies from 46 patients. Twenty-eight of the 53 samples had matched FFPE biopsies and were stained with a 12-plex panel including cell segmentation, immune and viral biomarkers. Corresponding serum samples were screened using the MSD Human V-plex Screen Service to identify peripheral correlates for the immune microenvironment. Results: Using unsupervised clustering of the transcriptome, we reveal two unique liver immune signatures classified as immune high and immune low based on the quantification of the liver infiltrate gene signatures. Multiplex immunofluorescence analysis demonstrated large periportal lymphoid aggregates in immune high samples consisting of CD4 and CD8 T cells, B cells and macrophages. Differentiation of the high and low immune microenvironments was independent of HBeAg status and peripheral viral antigen levels. In addition, longitudinal analysis indicates that treatment and normalization of ALT correlates with a decrease in liver immune infiltrate and inflammation. Finally, we screened a panel of peripheral biomarkers and identified ICAM-1 and CXCL10 as biomarkers that strongly correlate with these unique immune microenvironments. Conclusion: These data provide a description of immune phenotypes in patients with CHB and show that immune responses are downregulated in the liver following nucleotide analogue treatment. This may have important implications for both the safety and efficacy of immune modulator programs aimed at HBV cure. Lay summary: Liver biopsies from patients with chronic hepatitis B were submitted to RNA-Seq and multiplex immunofluorescence and identified two different liver immune microenvironments: immune high and immune low. Immune high patients showed elevated immune pathways, including interferon signaling pathways, and increase presence of immune cells. Longitudinal analysis of biopsies from treatment experienced patients showed that treatment correlates with a marked decrease in inflammation and these findings may have important implications for both safety and efficacy of immune modulator programs for HBV cure.

A comprehensive 26‐color immunophenotyping panel to study the role of the gut‐liver axis in chronic liver diseases

Molecular and Cellular Mediators of the Gut-Liver Axis in the Progression of Liver Diseases

Role of the Immune System in Liver Transplantation and Its Implications for Therapeutic Interventions

Gut Microbiome, Liver Immunology, and Liver Diseases

The gut–liver axis and the intersection with the microbiome

A 30‐color spectral flow cytometry panel for comprehensive analysis of immune cell composition and macrophage subsets in mouse metabolic organs

The Gut-liver Axis in Immune Remodeling: New insight into Liver Diseases

Crosstalk Between Liver Macrophages and Gut Microbiota: an Important Component of Inflammation-Associated Liver Diseases

Gut-liver Axis: Gut Microbiota in Shaping Hepatic Innate Immunity

The liver as an immunological barrier redefined by single‐cell analysis

[The gut-liver axis: how the gut promotes liver disease]

The gut-liver axis in immune remodeling of hepatic cirrhosis

Interorgan communication with the liver: novel mechanisms and therapeutic targets

Precision-cut human liver slice cultures as an immunological platform

Multiparametric Flow Cytometry-Based Immunophenotyping of Mouse Liver Immune Cells

34-parameter full spectrum immunophenotyping panel of human regulatory and effector lymphocytes

OMIP 082: A 25‐color phenotyping to define human innate lymphoid cells, natural killer cells, mucosal‐associated invariant T cells, and γδ T cells from freshly isolated human intestinal tissue

Characterization of the liver immune microenvironment in liver biopsies from patients with chronic HBV infection

Gut Microbiota Targeted Approach in the Management of Chronic Liver Diseases

The Role of Gut Microbiota in Some Liver Diseases: From an Immunological Perspective

OMIP‐095: 40‐Color spectral flow cytometry delineates all major leukocyte populations in murine lymphoid tissues